Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
6,203,359
-
Share change
-
-120,364
-
Total reported value
-
$5,927,524
-
Put/Call ratio
-
2.3%
-
Price per share
-
$0.95
-
Number of holders
-
20
-
Value change
-
-$120,184
-
Number of buys
-
4
-
Number of sells
-
8
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2023
As of 30 Jun 2023,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,203,359 shares.
The largest 10 holders included
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, STONEHILL CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, Whitefort Capital Management, LP, Aristides Capital LLC, Cambridge Investment Research Advisors, Inc., MORGAN STANLEY, CITADEL ADVISORS LLC, and WEALTHSOURCE PARTNERS, LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.